Taken together, the results identified a novel PARylation-regulated ATF4-GDF15 pathway governing autophagy, ferroptosis, and mitophagy in ATM-deficient CRC cells (Fig. 7), which can contribute to BMN673-induced anticancer effects alone or in combination with RT. The gene discussed is ATM; the disease is colorectal carcinoma.